scott rollins

scott rollins is from Oklahoma City, Oklahoma, United States. scott is currently Chief Executive Officer and Chairman at Moat Biotechnology, located in Oklahoma City, Oklahoma, United States. scott also works as CEO and Chairman of the BOD at Tetherex Pharmaceuticals, a job scott has held since Jun 2013. In scott's previous role as a President & CEO at Selexys Pharmaceuticals (Sold to Novartis for $665M), scott worked in until Nov 2016. Prior to joining Selexys Pharmaceuticals (Sold to Novartis for $665M), scott was a Cofounder and Senior Vice President at Alexion Pharmaceuticals, Inc. and held the position of Cofounder and Senior Vice President.